Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Takeda
Centre Oscar Lambret
Centre Oscar Lambret
University of Texas Southwestern Medical Center
Cedars-Sinai Medical Center
University Hospital, Akershus
University of California, San Diego
M.D. Anderson Cancer Center
AbbVie
Pfizer
National Institutes of Health Clinical Center (CC)
Reveal Pharmaceuticals Inc.
Boston Children's Hospital
University Hospital, Lille
Assistance Publique - Hôpitaux de Paris
Pfizer
Bayer
University of Kentucky
Eikon Therapeutics
Institut de Cancérologie de Lorraine
University of California, San Diego
BioAtla, Inc.
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
University of California, San Diego
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Sheba Medical Center
GlaxoSmithKline
Azienda USL Reggio Emilia - IRCCS
Verrica Pharmaceuticals Inc.
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
Celgene
PhytoHealth Corporation
Pfizer
M.D. Anderson Cancer Center
Celgene
Swiss Cancer Institute
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
Thomas Jefferson University
Gustave Roussy, Cancer Campus, Grand Paris
Theriva Biologics SL
BPGbio
Ohio State University Comprehensive Cancer Center
Juno Therapeutics, a Subsidiary of Celgene
Celgene
The Christie NHS Foundation Trust